Nektar Therapeutics Prices $100 Mln Public Offering Of Common Stock At $23.50 Per Share
3/7 05:25
(RTTNews) - Nektar Therapeutics (NKTR), a clinical-stage biotech firm specializing in immunotherapy, has priced its underwritten public offering of approximately $100 million in common stock....